Biogen
BIIB
BIIB
738 hedge funds and large institutions have $60.8B invested in Biogen in 2013 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 247 increasing their positions, 264 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 656 → 738 (+82)
6% less repeat investments, than reductions
Existing positions increased: 247 | Existing positions reduced: 264
Holders
738
Holding in Top 10
37
Calls
$913M
Puts
$771M
Top Buyers
| 1 | +$230M | |
| 2 | +$201M | |
| 3 | +$173M | |
| 4 |
Morgan Stanley
New York
|
+$109M |
| 5 |
Barclays
London,
United Kingdom
|
+$97.8M |
Top Sellers
| 1 | -$533M | |
| 2 | -$447M | |
| 3 | -$166M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$135M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$134M |